(Total Views: 523)
Posted On: 09/08/2021 1:15:31 AM
Post# of 145909
I was incorrect. But it did get me interested in why leronlimab would still remain so effective in the face of cell to cell transfer. Leronlimab's downregulation of the PI3K/AKT pathway may inhibit glycosylation and cell adhesion.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)